Kairos Pharma, Ltd (KAPA) insider trading
Every open-market stock purchase and sale by Kairos Pharma, Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Ramachandran Murali (VP), $318, 22 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent KAPA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 8, 2025 | John S Yu (CEO) | Bought (not open market) | — |
| Oct 8, 2025 | Hansoo Michael Keyoung (Director) | Bought (not open market) | — |
| Oct 8, 2025 | Ramachandran Murali (VP) | Bought (not open market) | — |
| Oct 8, 2025 | Doug Samuelson (CFO) | Bought (not open market) | — |
| Oct 8, 2025 | Rahul Singhvi (Director) | Bought (not open market) | — |
| Oct 8, 2025 | Hyun W. Bae (Director) | Bought (not open market) | — |
| Oct 8, 2025 | Neil Bhowmick (C-suite exec) | Bought (not open market) | — |
Who's trading KAPA
- Hyun W. Bae, Director: other filings, last Oct 8, 2025
- Neil Bhowmick, C-suite exec: other filings, last Oct 8, 2025
- Hansoo Michael Keyoung, Director: other filings, last Oct 8, 2025
- Ramachandran Murali, VP: other filings, last Oct 8, 2025
- Doug Samuelson, CFO: other filings, last Oct 8, 2025
- Rahul Singhvi, Director: other filings, last Oct 8, 2025
- John S Yu, CEO: other filings, last Oct 8, 2025
Get free alerts when an insider at Kairos Pharma, Ltd files a new trade →